These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19739070)
1. Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38. Bhonde MR; Hanski ML; Stehr J; Jebautzke B; Peiró-Jordán R; Fechner H; Yokoyama KK; Lin WC; Zeitz M; Hanski C Int J Cancer; 2010 Jun; 126(12):2813-25. PubMed ID: 19739070 [TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38. Hapke G; Yin MB; Wu J; Frank C; Rustum YM Int J Oncol; 2002 Nov; 21(5):1059-66. PubMed ID: 12370755 [TBL] [Abstract][Full Text] [Related]
3. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. Magrini R; Bhonde MR; Hanski ML; Notter M; Scherübl H; Boland CR; Zeitz M; Hanski C Int J Cancer; 2002 Sep; 101(1):23-31. PubMed ID: 12209584 [TBL] [Abstract][Full Text] [Related]
4. CPT-11 (SN-38) chemotherapy may be selectively applicable to biliary tract cancer with low hMLH1 expression. Sato K; Kitajima Y; Kohya N; Koga Y; Ohtaka K; Miyazaki K Anticancer Res; 2007; 27(2):865-72. PubMed ID: 17465213 [TBL] [Abstract][Full Text] [Related]
5. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses. Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709 [TBL] [Abstract][Full Text] [Related]
6. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359 [TBL] [Abstract][Full Text] [Related]
7. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Jacob S; Aguado M; Fallik D; Praz F Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654 [TBL] [Abstract][Full Text] [Related]
8. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells. Park JM; Huang S; Tougeron D; Sinicrope FA PLoS One; 2013; 8(5):e65369. PubMed ID: 23724141 [TBL] [Abstract][Full Text] [Related]
9. Role of hMLH1 in sterigmatocystin-induced G₂ phase arrest in human esophageal epithelial Het-1A cells in vitro. Wang J; Huang S; Xing L; Shen H; Yan X; Wang J; Zhang X Toxicol Lett; 2013 Mar; 217(3):226-34. PubMed ID: 23296099 [TBL] [Abstract][Full Text] [Related]
10. The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. He G; Kuang J; Khokhar AR; Siddik ZH Gynecol Oncol; 2011 Aug; 122(2):402-9. PubMed ID: 21592546 [TBL] [Abstract][Full Text] [Related]
11. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells. Yan T; Berry SE; Desai AB; Kinsella TJ Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402 [TBL] [Abstract][Full Text] [Related]
12. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation. Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462 [TBL] [Abstract][Full Text] [Related]
13. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells. Qi Y; Schoene NW; Lartey FM; Cheng WH J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753 [TBL] [Abstract][Full Text] [Related]
14. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells. Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911 [TBL] [Abstract][Full Text] [Related]
15. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines. Chang DK; Goel A; Ricciardiello L; Lee DH; Chang CL; Carethers JM; Boland CR Cancer Lett; 2003 Jun; 195(2):243-51. PubMed ID: 12767533 [TBL] [Abstract][Full Text] [Related]
16. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis. Bhonde MR; Hanski ML; Budczies J; Cao M; Gillissen B; Moorthy D; Simonetta F; Scherübl H; Truss M; Hagemeier C; Mewes HW; Daniel PT; Zeitz M; Hanski C J Biol Chem; 2006 Mar; 281(13):8675-85. PubMed ID: 16446370 [TBL] [Abstract][Full Text] [Related]
17. DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis. Li LS; Morales JC; Hwang A; Wagner MW; Boothman DA J Biol Chem; 2008 Aug; 283(31):21394-403. PubMed ID: 18480060 [TBL] [Abstract][Full Text] [Related]
18. Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth. Bhonde MR; Hanski ML; Notter M; Gillissen BF; Daniel PT; Zeitz M; Hanski C Oncogene; 2006 Jan; 25(2):165-75. PubMed ID: 16170360 [TBL] [Abstract][Full Text] [Related]
19. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage. Gogolin S; Ehemann V; Becker G; Brueckner LM; Dreidax D; Bannert S; Nolte I; Savelyeva L; Bell E; Westermann F Cell Cycle; 2013 Apr; 12(7):1091-104. PubMed ID: 23462184 [TBL] [Abstract][Full Text] [Related]
20. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]